Publicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (10)

2022

  1. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study

    BMC Cancer, Vol. 22, Núm. 1

2021

  1. Pembrolizumab plus gemcitabine in the subset of triple-negative advanced breast cancer patients in the geicam/2015-04 (Pangea-breast) study

    Cancers, Vol. 13, Núm. 21

2020

  1. The evolving microbiome from pregnancy to early infancy: A comprehensive review

    Nutrients, Vol. 12, Núm. 1

2017

  1. 18F-fluoromisonidazole PET and activity of neoadjuvant nintedanib in early HER2-negative breast cancer: A window-of-opportunity randomized trial

    Clinical Cancer Research, Vol. 23, Núm. 6, pp. 1432-1441

  2. Critically short telomeres and toxicity of chemotherapy in early breast cancer

    Oncotarget, Vol. 8, Núm. 13, pp. 21472-21482

2016

  1. Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile

    Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428

2015

  1. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast

    Molecular Oncology, Vol. 9, Núm. 6, pp. 1081-1090

2012

  1. Cultural adaptation and validation of the painDETECT scale into Spanish

    Clinical Journal of Pain, Vol. 28, Núm. 3, pp. 243-253

2010

  1. Editorial: Whither thou goest pain?

    Revista de la Sociedad Espanola del Dolor, Vol. 17, Núm. 4, pp. 187-189

2009

  1. Nonpegylated liposomal doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-overexpressing breast cancer: A multicenter phase l/ll study

    Clinical Cancer Research, Vol. 15, Núm. 1, pp. 307-314